Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)

NCT00670306 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hypertrophy

Interventions

DRUG: Cetrorelix Pamoate

Sponsor

AEterna Zentaris